Adhere+ Celebrates Top Clinical Abstract Award at Conference
Adhere+ Earns Top Abstract Recognition at Industry Meeting
Real-world data from 844,000 patient records highlights the power of remote therapeutic monitoring to improve outcomes and reduce risks in chronic pain care.
Adhere+, a telehealth company dedicated to enhancing patient outcomes through technology, proudly announced that its abstract titled "Improving Engagement and Outcomes in Chronic Pain Management: Multi-Specialty Real-World Evidence from a Remote Therapeutic Monitoring Platform" has been awarded the prestigious Top Abstract honor at the recent "Business of Pain" meeting. This significant recognition will be celebrated during the awards ceremony, where Dan Cohen, President and Co-Founder of Adhere+, will present the abstract.
The research showcased in the abstract is a retrospective cohort analysis focused on over 2.7 million electronic patient-reported outcomes collected via the Adhere+ platform over several years, capturing data from 844,000 unique patients across 40 outpatient clinics. This extensive study involved multiple specialties, including pain management, neurology, orthopedic, bariatrics, and primary care. Findings indicate that the Adhere+ platform effectively facilitated vital improvements in managing anxiety, depression, fatigue, and pain, demonstrating a strong adherence rate above 75% among most patient groups involved.
Dan Cohen expressed his satisfaction with the results, commenting, "These findings illustrate the effectiveness of remote therapeutic monitoring to enhance patient engagement and outcomes while providing timely support for healthcare providers. It’s an honor to be recognized by the Business of Pain for this impactful work that aims to revolutionize chronic pain care."
The analysis revealed statistically significant improvements: anxiety decreased by 30.4%, depression reduced by 17.1%, fatigue by 17.2%, and pain levels by 6.1% over an 18-week follow-up period. An essential aspect of the data analysis indicated that in over 35% of monitored cases, alerts were issued to providers, enabling prompt interventions that could have been overlooked during regular patient visits.
Dr. Lynn Webster, prominent in the field of pain management and lead co-author of the study, emphasized the importance of these findings. "This real-world evidence paves the way for a proactive, patient-centered approach to pain management, especially in today’s healthcare landscape, where the balance between safety, efficacy, and efficiency is paramount."
Given that chronic pain impacts more than 50 million Americans, with ongoing challenges around opioid dependence, Adhere+ is dedicated to providing a scalable solution that promotes early intervention, decreases the burden on healthcare providers, and assists patients in maintaining treatment adherence between appointments. The platform facilitates daily check-ins, enabling patients to report their progress while offering healthcare professionals immediate insights that ease administrative demands.
Event Information for The Business of Pain Conference
This notable event, titled "The Next Big Thing: Where Pain Medicine, Science, and Business Intersect," aims to bring together various stakeholders involved in pain management innovation. The event will take place from October 23 to October 26 of a future year at the elegant Eden Roc in Miami Beach.
About Adhere+
Adhere+ focuses on ensuring compliance with medical treatments for individuals dealing with chronic conditions such as pain and substance use disorders. Their SaaS platform is clinically validated through multiple published studies, ensuring its effectiveness. The goal is to create a streamlined, user-friendly digital experience, providing physicians with evidence-based telehealth interventions that improve adherence to treatment plans, yielding better health outcomes and cost efficiencies.
Contact Information
For inquiries related to investment, reach out to Tiberend Strategic Advisors, Inc. Jon Nugent can be contacted directly for assistance.
For media inquiries, Eric Reiss is available for discussions regarding the company’s initiatives and developments.
Lastly, Dan Cohen can be reached for matters directly relating to Adhere+ and its endeavors in enhancing patient care.
Frequently Asked Questions
What is Adhere+?
Adhere+ is a telehealth company that specializes in promoting patient compliance in chronic disease management through innovative technology solutions.
What recognition did Adhere+ recently receive?
The company was awarded the Top Abstract honor at the Business of Pain meeting for its research in chronic pain management.
How does Adhere+ enhance patient care?
The platform utilizes remote therapeutic monitoring to provide real-time insights that facilitate better treatment adherence and patient outcomes.
What special data was presented in the winning abstract?
The abstract detailed a study of over 2.7 million electronic patient-reported outcomes showing significant improvements in mental health and chronic pain symptoms.
Where was the Business of Pain meeting held?
The conference took place at the Eden Roc in Miami Beach, bringing together leaders from various fields in pain management.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.